Literature DB >> 17968620

Factors limiting complete tumor ablation by radiofrequency ablation.

Erwan Paulet1, Christophe Aubé, Patrick Pessaux, Jerome Lebigot, Emilie Lhermitte, Frederic Oberti, Anne Ponthieux, Paul Calès, Catherine Ridereau-Zins, Philippe L Pereira.   

Abstract

The purpose of this study was to determine radiological or physical factors to predict the risk of residual mass or local recurrence of primary and secondary hepatic tumors treated by radiofrequency ablation (RFA). Eighty-two patients, with 146 lesions (80 hepatocellular carcinomas, 66 metastases), were treated by RFA. Morphological parameters of the lesions included size, location, number, ultrasound echogenicity, computed tomography density, and magnetic resonance signal intensity were obtained before and after treatment. Parameters of the generator were recorded during radiofrequency application. The recurrence-free group was statistically compared to the recurrence and residual mass groups on all these parameters. Twenty residual masses were detected. Twenty-nine lesions recurred after a mean follow-up of 18 months. Size was a predictive parameter. Patients' sex and age and the echogenicity and density of lesions were significantly different for the recurrence and residual mass groups compared to the recurrence-free group (p < 0.05). The presence of an enhanced ring on the magnetic resonance control was more frequent in the recurrence and residual mass groups. In the group of patients with residual lesions, analysis of physical parameters showed a significant increase (p < 0.05) in the time necessary for the temperature to rise. In conclusion, this study confirms risk factors of recurrence such as the size of the tumor and emphasizes other factors such as a posttreatment enhanced ring and an increase in the time necessary for the rise in temperature. These factors should be taken into consideration when performing RFA and during follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 17968620     DOI: 10.1007/s00270-007-9208-1

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  14 in total

1.  Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients.

Authors:  Roberto Santambrogio; Matteo Barabino; Savino Bruno; Mara Costa; Andrea Pisani Ceretti; Maria Rachele Angiolini; Massimo Zuin; Franca Meloni; Enrico Opocher
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

Review 2.  Thermal ablation of tumours: biological mechanisms and advances in therapy.

Authors:  Katrina F Chu; Damian E Dupuy
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

3.  Science to Practice: Molecular-targeted Drug Delivery in Combination with Radiofrequency Ablation of Liver Cancer: A Magic Bullet?

Authors:  Lucas Christoph Adam; Nikitha Murali; Julius Chapiro; Jean-François Geschwind
Journal:  Radiology       Date:  2017-11       Impact factor: 11.105

4.  RF field visualization of RF ablation at the Larmor frequency.

Authors:  Kim Shultz; Pascal Stang; Adam Kerr; John Pauly; Greig Scott
Journal:  IEEE Trans Med Imaging       Date:  2011-07-18       Impact factor: 10.048

5.  Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study.

Authors:  Nikolaos Tselis; Georgios Chatzikonstantinou; Christos Kolotas; Natasa Milickovic; Dimos Baltas; Nikolaos Zamboglou
Journal:  Eur Radiol       Date:  2013-03-21       Impact factor: 5.315

6.  Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival.

Authors:  Philipp Wiggermann; Ralf Puls; Andrej Vasilj; Dominik Sieroń; Andreas G Schreyer; Ernst-Michael Jung; Wojciech Wawrzynek; Christian Stroszczynski
Journal:  Med Sci Monit       Date:  2012-02

Review 7.  More than just tumor destruction: immunomodulation by thermal ablation of cancer.

Authors:  Sebastian P Haen; Philippe L Pereira; Helmut R Salih; Hans-Georg Rammensee; Cécile Gouttefangeas
Journal:  Clin Dev Immunol       Date:  2011-12-29

8.  Neural stem cell-mediated intratumoral delivery of gold nanorods improves photothermal therapy.

Authors:  Rachael Mooney; Luella Roma; Donghong Zhao; Desiree Van Haute; Elizabeth Garcia; Seung U Kim; Alexander J Annala; Karen S Aboody; Jacob M Berlin
Journal:  ACS Nano       Date:  2014-11-17       Impact factor: 15.881

9.  Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy.

Authors:  Rahul A Sheth; Xiaoxia Wen; Junjie Li; Marites P Melancon; Xin Ji; Y Andrew Wang; Cheng-Hui Hsiao; Diana S-L Chow; Elizabeth M Whitley; Chun Li; Sanjay Gupta
Journal:  Cancer Nanotechnol       Date:  2020-07-01

10.  Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence.

Authors:  Petra G Kele; Eric J Van der Jagt; Paul F M Krabbe; Koert P de Jong
Journal:  Int J Hepatol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.